What's breaking now, across thousands of outlets.
Plus news about RevMed, Tang Capital, GSK and AmyriAD Therapeutics. Nuvig Therapeutics ends one of two trials: The biotech axed a Phase 2 study of its candidate NVG-2089 in patients with chronic inflammatory demyelinating polyneuropathy ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Bibiani Anhwiaso Bekwai Municipal Health Directorate in the Western North Region has recorded more than 200 dog bite cases and four rabies-related deaths between January and October this year.
Taking opioids for years does not seem to reduce pain or improve functioning in people with chronic back pain, according to a new Northwestern University study that compared 70 long-term opioid users…
Orihuela’s Health and Education departments have launched a new school campaign aimed at teaching young children about the importance of a healthy, varied and balanced diet.
A Dutch court barred Merck from selling subcutaneous Keytruda in several European countries. Elsewhere, an Insmed executive ended a seven-year run and two startups secured venture cash.
The holding company of Canada’s Weston family ‌said on Wednesday that it has agreed to buy the British pharmacy chain Boots for $8.9 billion, including ‌debt.
A psychiatrist, Dr Abayomi Olajide, has urged the government to declare a state of emergency on substance abuse, warning it is worsening Nigeria’s mental h Read More…
